# Filing Detail

Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001144204-15-000474
Filing Date
2015-01-05
Accepted
2015-01-05 16:42:52
Documents
9

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B3 | v398030_424b3.htm | 424B3 | 2419427
2 | GRAPHIC | logo_ampliphi-biocorp2.jpg | GRAPHIC | 6727
3 | GRAPHIC | spacer.gif | GRAPHIC | 43
4 | GRAPHIC | line.gif | GRAPHIC | 43
5 | GRAPHIC | v367027_img-mice.jpg | GRAPHIC | 144717
6 | GRAPHIC | v367027_chrt-line.jpg | GRAPHIC | 64302
7 | GRAPHIC | v365643_chrt-scatter1.jpg | GRAPHIC | 35363
8 | GRAPHIC | v365643_chrt-scatter2.jpg | GRAPHIC | 47329
9 | GRAPHIC | v365643_img-lifecycle.jpg | GRAPHIC | 30268
| Complete submission text file | 0001144204-15-000474.txt |  | 2874778

Mailing Address 4870 SADLER ROAD SUITE 300 GLEN ALLEN VA 23060
Business Address 4870 SADLER ROAD SUITE 300 GLEN ALLEN VA 23060 650-888-2422
AmpliPhi Biosciences Corp (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-193458 | Film No.: 15505588
SIC: 2836 Biological Products, (No Diagnostic Substances)